As IL-8 is anti-apoptotic, and TRAIL is pro-apoptotic, the presence of IL-8 in ovarian cancer cells and microenvironment complicates or even prevents therapeutic use of TRAIL [63]. This evidence concerns the gene TNFSF10 and ovarian cancer.